v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 28,536 $ 11,284
Cost of revenue 22,796 13,645
Gross profit (loss) 5,740 (2,361)
Operating expenses:    
Research and development 3,799 2,003
Selling, general and administrative 8,628 5,307
Total operating expenses 12,427 7,310
Loss from operations (6,687) (9,671)
Other income, net 1,641 300
Net loss $ (5,046) $ (9,371)
Weighted-average common shares outstanding:    
Weighted-average common shares outstanding, basic (in shares) 136,947,076 117,969,812
Weighted-average common shares outstanding, diluted (in shares) 136,947,076 117,969,812
Net loss per share of common stock:    
Net loss per share of common stock, basic (in dollars per share) $ (0.04) $ (0.08)
Net loss per share of common stock, diluted (in dollars per share) $ (0.04) $ (0.08)

Source